{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:56:17Z","timestamp":1787162177018,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Inulin may be a promising therapeutic molecule for treating non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanisms of its therapeutic activity remain unclear. To address this issue, a high-fat-diet-induced NAFLD mouse model was developed and treated with inulin. The NAFLD phenotype was evaluated via histopathological analysis and biochemical parameters, including serum levels of alanine aminotransferase, aspartate aminotransferase, liver triglycerides, etc. A serum metabolomics study was conducted using ultra-performance liquid chromatography coupled with tandem mass spectrometry. The results revealed that inulin mitigated NAFLD symptoms such as histopathological changes and liver cholesterol levels. Through the serum metabolomics study, 347 differential metabolites were identified between the model and control groups, and 139 differential metabolites were identified between the inulin and model groups. Additionally, 48 differential metabolites (such as phosphatidylserine, dihomo-\u03b3-linolenic acid, L-carnitine, and 13-HODE) were identified as candidate targets of inulin and subjected to pathway enrichment analysis. The results revealed that these 48 differential metabolites were enriched in several metabolic pathways such as fatty acid biosynthesis and cardiolipin biosynthesis. Taken together, our results suggest that inulin might attenuate NAFLD partially by modulating 48 differential metabolites and their correlated metabolic pathways, constituting information that might help us find novel therapies for NAFLD.<\/jats:p>","DOI":"10.3390\/ph17070895","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:40:50Z","timestamp":1720449650000},"page":"895","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum Metabolomics Uncovers the Mechanisms of Inulin in Preventing Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7050-8940","authenticated-orcid":false,"given":"Yunhong","family":"Sun","sequence":"first","affiliation":[{"name":"School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"},{"name":"Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-6414","authenticated-orcid":false,"given":"Mingzhe","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nassir, F. (2022). NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12.","DOI":"10.3390\/biom12060824"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rong, L., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., and Guo, J. (2022). Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1087260"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.carbpol.2013.09.081","article-title":"Inulin-type fructans: A review on different aspects of biochemical and pharmaceutical technology","volume":"101","author":"Apolinario","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1039\/D2FO01096H","article-title":"Inulin: Properties and health benefits","volume":"14","author":"Qin","year":"2023","journal-title":"Food Funct."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wu, Z., Du, Z., Tian, Y., Liu, M., Zhu, K., Zhao, Y., and Wang, H. (2022). Inulin accelerates weight loss in obese mice by regulating gut microbiota and serum metabolites. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.980382"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chong, C.Y.L., Orr, D., Plank, L.D., Vatanen, T., O\u2019Sullivan, J.M., and Murphy, R. (2020). Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12040937"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, C., Fang, T., Shi, L., Wang, Y., Deng, X., Wang, J., and Zhou, Y. (2024). The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiota. J. Nutr. Biochem., 125.","DOI":"10.1016\/j.jnutbio.2023.109546"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"112309","DOI":"10.1016\/j.foodres.2022.112309","article-title":"Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function","volume":"163","author":"Yang","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Perez-Monter, C., Alvarez-Arce, A., Nuno-Lambarri, N., Escalona-Nandez, I., Juarez-Hernandez, E., Chavez-Tapia, N.C., Uribe, M., and Barbero-Becerra, V.J. (2022). Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020991"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for Investigating Physiological and Pathophysiological Processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhu, G., Wang, Y., Wang, W., Shang, F., Pei, B., Zhao, Y., Kong, D., and Fan, Z. (2021). Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.729512"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mas.21562","article-title":"Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases","volume":"37","author":"Cui","year":"2018","journal-title":"Mass Spectrom. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wen, M., Dang, X., Feng, S., He, Q., Li, X., Liu, T., and He, X. (2021). Integrated Analyses of Gut Microbiome and Host Metabolome in Children with Henoch-Schonlein Purpura. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.796410"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2100284","DOI":"10.1183\/13993003.00284-2021","article-title":"Metabolomic analyses reveal new stage-specific features of COVID-19","volume":"59","author":"Jia","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: A microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.csbj.2024.01.007","article-title":"Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese","volume":"23","author":"Chen","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmsacl.2021.10.001","article-title":"A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease","volume":"22","author":"He","year":"2021","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1007\/s00210-023-02864-0","article-title":"Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats","volume":"397","author":"Zhao","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115268","DOI":"10.1016\/j.jep.2022.115268","article-title":"Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis","volume":"293","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.thromres.2014.03.022","article-title":"Differential roles of tissue factor and phosphatidylserine in activation of coagulation","volume":"133","author":"Spronk","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Copic, A., Dieudonne, T., and Lenoir, G. (2023). Phosphatidylserine transport in cell life and death. Curr. Opin. Cell Biol., 83.","DOI":"10.1016\/j.ceb.2023.102192"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/acs.molpharmaceut.2c00707","article-title":"Phosphatidylserine in Diabetes Research","volume":"20","author":"Xiao","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","article-title":"Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease","volume":"177","author":"Sebastian","year":"2019","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-19-2332","article-title":"Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling","volume":"80","author":"Tan","year":"2020","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-511X-11-25","article-title":"Multiple roles of dihomo-gamma-linolenic acid against proliferation diseases","volume":"11","author":"Wang","year":"2012","journal-title":"Lipids Health Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mustonen, A.M., and Nieminen, P. (2023). Dihomo-gamma-Linolenic Acid (20:3n-6)-Metabolism, Derivatives, and Potential Significance in Chronic Inflammation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032116"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/obr.12280","article-title":"Long-chain polyunsaturated fatty acid status in obesity: A systematic review and meta-analysis","volume":"16","author":"Fekete","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2169\/internalmedicine.0816-18","article-title":"Increased Serum Dihomo-gamma-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes","volume":"57","author":"Tsurutani","year":"2018","journal-title":"Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/lipd.12251","article-title":"Alteration of Serum Phospholipid n-6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross-Sectional Study","volume":"55","author":"Jiang","year":"2020","journal-title":"Lipids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.orcp.2016.02.004","article-title":"Predictive value of serum dihomo-gamma-linolenic acid level and estimated Delta-5 desaturase activity in patients with hepatic steatosis","volume":"11","author":"Matsuda","year":"2017","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain","volume":"42","author":"Ferreira","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Savic, D., Hodson, L., Neubauer, S., and Pavlides, M. (2020). The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12082178"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102273","DOI":"10.1016\/j.ctim.2019.102273","article-title":"The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Abolfathi","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.prostaglandins.2012.06.001","article-title":"Lipidic last breath of life in patients with alcoholic liver disease","volume":"99","author":"Safranow","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Maciejewska, D., Drozd, A., Skonieczna-Zydecka, K., Skorka-Majewicz, M., Dec, K., Jakubczyk, K., Pilutin, A., and Stachowska, E. (2020). Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?. Molecules, 25.","DOI":"10.3390\/molecules25092026"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","article-title":"Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Abulikemu, A., Zhao, X., Xu, H., Li, Y., Ma, R., Yao, Q., Wang, J., Sun, Z., Li, Y., and Guo, C. (2023). Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biol., 59.","DOI":"10.1016\/j.redox.2022.102569"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhu, M., Wang, X., Wang, K., Zhao, Z., Dang, Y., Ji, G., Li, F., and Zhou, W. (2023). Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1066053"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/7\/895\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:10:41Z","timestamp":1760109041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/7\/895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ph17070895"],"URL":"https:\/\/doi.org\/10.3390\/ph17070895","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}